Insulin shortage blamed on Ozempic craze

Insulin shortage blamed on Ozempic craze

The Department of Health in KwaZulu-Natal has blamed a shortage of insulin on the global Ozempic frenzy.

Insulin shortage blamed on Ozempic craze
AFP

The medication, meant to regulate blood sugar levels, is being used as a weight-loss drug. 

 

The Department's head of Pharmaceutical Services, Vusi Dlamini, has told the KZN legislature’s health portfolio committee that the Ozempic trend is impacting the manufacturing of insulin. 

 

" Because then it is packaged either as pens or vials and then because Ozempic is produced as pens, they've favoured Ozempic for those production lines, reducing the production of pens. Then insulin largely becomes available as the vials. Then we see that as a shortage in pens practically on the ground."

 READ: KZN police uncover R1.5m illegal liquor operation

However, committee chairperson Imran Keeka doesn't believe that's a satisfactory reason for the shortage. 

 

He said the issue is more complex than people hopping on a new trend.

 

" I think the issue of insulin pen shortages at the door of Ozempic is something I cannot accept. I cannot accept this because, like I said to you, it's available everywhere else. You're not telling me about its availability everywhere else, and you placed it at the door of Ozempic. I don't think you should give us an answer like that. I think you must come back more prepared the next time that you come back."

 

Keeka said other concerns include a shortage of syringes, with patients reportedly reusing them and increasing their risk of infection. 


Find us on social media

Follow the ECR Newswatch WhatsApp channel here

We are also on Facebook and X (formerly Twitter) 

newswatch new banner 1

Show's Stories